Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 16,381-16,392 of 23,847
Drug study icon
CompletedNCT00257725

Long-Duration Stimulant Treatment Study of ADHD in Young Children

This study exists to explore whether the medication ADHD could improve care and understanding. Researchers are trying to understand whether the medication ADHD can improve attention, thinking, or day-to-day functioning.

In New York
ADHDDrugFrom 4 Years to 5 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
ADHD
Behavioral study icon
CompletedNCT05290311

Long-Term Effects of CBT on Quality of Life in Adults With ADHD

This study exists to understand how cognitive behavioural therapy, a structured talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

In Amsterdam
ADHDBehavioralOver 18 Years
Countries
Netherlands
Sponsor
Amsterdam UMC, location VUmc
Condition
ADHD
Drug study icon
CompletedNCT03250013

Long-term Effects of Medication for ADHD

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

In Gothenburg
ADHDDrugFrom 6 Years to 17 Years
Countries
Sweden
Sponsor
Göteborg University
Condition
ADHD
Other study type icon
CompletedEUCTR 2006-005674-47

Agomelatine for anxiety

This study is completed in Hungary, in Finland, in Sweden, .... It is testing agomelatine for anxiety.

In Hungary
AnxietyOther
Countries
Hungary, Finland, Sweden, ...
Sponsor
Institut de Recherches Internationales Servier
Condition
Anxiety
Drug study icon
CompletedNCT05825235

Long-term Efficacy of Pramipexole in Anhedonic Depression

This observational study is following people with Anhedonia or Depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Lund
DepressionDrugFrom 18 Years to 75 Years
Countries
Sweden
Sponsor
Region Skane
Condition
Depression
Drug study icon
CompletedNCT01614912

Long-term Extension Study of SM-13496 (Lurasidone HCl) in people with Schizophrenia

This study exists to understand whether the medication SM-13496 is both safe enough and useful enough to take further. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.

Multiple locations, including Tokyo, Etc
SchizophreniaDrugFrom 18 Years to 74 Years
Countries
Japan, Malaysia, South Korea, ...
Sponsor
Sumitomo Pharma Co., Ltd.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.